REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Laps to laptops: Formula One sells its big data know-how

Thu, 24th Oct 2013 20:57

By Jeremy Wagstaff

SINGAPORE, Oct 25 (Reuters) - Wander around the pits at aFormula One car race and you're as likely to bump into alaptop-wielding scientist or engineer as a mechanic with aspanner.

And the lessons they are drawing from sensors on F1 tracks,cars and drivers are finding their way into a surprising rangeof industries - from drilling oil wells to making toothpaste.

"By chance or whatever we've ended up that F1 is a verystrong metaphor for how the world is developing around a moreindustrialised Internet," says Peter van Manen, managingdirector of McLaren Electronic Systems, part of a group whichmakes F1 cars. "You take information and you measure things, andfrom that you try to adapt how things behave and flow, so youcan make performance better."

Formula One racing, born after World War II, has longembraced rapid innovation. It can take seven years to get anordinary car from the drawing board to the showroom: An F1 carmay take just five months ... and have new components added toit each race weekend.

"There are very few industries which have a similar abilityto evolve at such pace and bring components or products tomarket at such speed," says Gerard Spensley, AT&T's globalaccounts director for F1.

But in recent years safety concerns and fears it wouldbankrupt itself have forced the sport to adopt tighterregulations, reducing speeds and spending. This has shiftedemphasis from hardware upgrades to real-time tweaks inefficiency and tactics to prise an extra millisecond or two fromcar and driver.

To do that, teams capture gigabytes of data from more than100 sensors on each F1 car, transmitting it back to the pit ordirect to their UK headquarters over high-speed cables. Onceengineers have analysed the data they feed advice back to thedriver - often within minutes or even seconds.

At last year's Brazilian Grand Prix, for example, theInfiniti Red Bull Racing team's UK factory used AT&T's highbandwidth link to assess the impact of an early collision ondriver Sebastian Vettel's car in time to send instructions totrackside engineers ahead of the first pit stop. That gave themtime, AT&T's Spensley said, to make alterations that helpedreduce the risk of further damage to the car. Vettel finishedsixth, retaining his title.

It's this pressure-cooker data analytics which some F1companies say offers an edge not only to racing motor cars butto other industries grappling with big data. The appeal lies inhow F1 teams tackle grabbing information on the fly, figuringout what's important and then converting that quickly into astrategy.

COMPLEXITY

Leading the charge is McLaren, a racing car company foundedin 1963 and now half-owned by Bahrain Mumtalakat Holding Co. Itsapplied technologies unit last month set up its Asianheadquarters in Singapore.

McLaren, for example, has used its experience grabbing datafrom fast moving cars to help build a network of antennae,sensors and masts for San Francisco's Bay Area Rapid Transit(BART). The network is used to collect video surveillance of thecarriages, monitor usage and provide passengers with WiFi.

This is not, says McLaren's van Manen, as easy as it sounds.Data bounces off walls, arrives in the wrong order or drops outentirely. "The complexity is in the detail of dealing with boththe high volume of data and the imperfections in the world."

McLaren is now working on similar projects in Europe.

To be sure, F1 is a small industry and McLaren is beingdriven in part by circumstance to seek new markets. In 2012 thegroup made a pre-tax loss of 2.5 million pounds ($4.05 million).The global market for big data is expected to be worth $23.7billion by 2016, most of it driven by big players such as IBM, Cisco Systems Inc and EMC Corp,forecasts Credit Suisse.

BRAND APPEAL

Not all in the industry are convinced there's much mileagein exporting its expertise.

"There is relevance but our analysis of the marketplace isthat we're far better concentrating very strongly on automotiveand other forms of motor sports," says Paul Newsome of WilliamsF1, whose hybrid engine technology is being tested on buses.

And even those who partner with F1 acknowledge that part ofits appeal is the brand. Paul Marriott of SAP, whosereal-time data analytics product HANA is being road-tested byMcLaren, says the company also benefits from the glamorousassociation with F1. A McLaren car sits in the company'sSingapore office.

But the partnerships run deeper. McLaren is working withU.S.-based IO Data Centers LLC to make data centers moreefficient by modelling likely demand.

"Every plane and car is now driven by software, constantlyadjusting every variable. Taking that thinking and applying itto the data center - where every input is constantly monitoredand controlled - was how the partnership was spun with McLaren,"IO's chief innovation officer Kevin Malik said in an interviewat the company's new Singapore data center.

The way McLaren uses predictive analytics to figure out thebest time to call a racing car in for a pit-stop is helpingBritain's airport controllers anticipate which planes shouldland on what runway. The software is currently being deployed atLondon's Heathrow Airport, according to McLaren.

McLaren is also working with an oil and gas company tofigure out the optimal path to drill through a honeycomb ofwells 10 miles underground. The solution, says McLaren's GeoffMcGrath, is a strategy straight out of racing: measure thecondition of the car, mine the models using historical data andthen advise a course of action - which will change all the timeas new events occur.

MANUFACTURING PIT STOPS

No action is too mundane for F1 to capture and analyse.Teams of mechanics practice changing wheels and tyres dozens oftimes a day, each session captured by video monitors and thenstudied for lessons.

This caught the eye of GlaxoSmithKline Plc, whichasked McLaren to help reduce the time spent switching itstoothpaste production lines. By standardizing materials, makingthe machines easier to handle and reviewing teams' performanceafter every batch, they cut the changeovers from 39 minutes to15.

"Changeovers in the manufacturing world are very like pitstops in an F1 team," says GSK's global manufacturing and supplychief, Roger Connor.

That said, the success of F1 teams in marketing theirexpertise to other industries may have less to do with theircutting edge innovation, than with their high profile work.

"It isn't so much the technology and methods that aredriving, but that these cases are so interesting that people arestarting to pay attention to things like sensors in thevehicle," says Craig Stires, a Singapore-based analyst with IDC."It creates that interest that radiates into other industries."

Whatever the reason, F1's innovation is causing ripples.Providing high-speed connectivity to F1, for example, has helpedcompanies like AT&T and Tata Communications theirservices overall.

Normally, setting up a network for a client would take 10weeks, Tata Communications chief marketing officer JulieWoods-Moss. F1 needs to have it done in three days. "So there'sbeen huge process innovations in the company that now we'restarting to see feeding to mainstream customers."

More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.